In AML, including MLL-rearranged leukemia, inhibition of LSD1 abrogates the clonogenic potential, directly promotes differentiation or sensitizes to differentiation-therapy by all-trans-retinoic acid [173,174]. Here, KMT2A is linked to acute myeloid leukemia.